66 related articles for article (PubMed ID: 26026677)
1. The novel HDAC inhibitor AR-42-induced anti-colon cancer cell activity is associated with ceramide production.
Xu W; Xu B; Yao Y; Yu X; Shen J
Biochem Biophys Res Commun; 2015 Aug; 463(4):545-50. PubMed ID: 26026677
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production.
Gong L; Yang B; Xu M; Cheng B; Tang X; Zheng P; Jing Y; Wu GJ
Cancer Chemother Pharmacol; 2014 Jan; 73(1):69-77. PubMed ID: 24190701
[TBL] [Abstract][Full Text] [Related]
3. Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways.
Chen YJ; Wang WH; Wu WY; Hsu CC; Wei LR; Wang SF; Hsu YW; Liaw CC; Tsai WC
PLoS One; 2017; 12(8):e0183368. PubMed ID: 28829799
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer.
Selzner M; Bielawska A; Morse MA; Rüdiger HA; Sindram D; Hannun YA; Clavien PA
Cancer Res; 2001 Feb; 61(3):1233-40. PubMed ID: 11221856
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma.
Lu YS; Chou CH; Tzen KY; Gao M; Cheng AL; Kulp SK; Cheng JC
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e181-9. PubMed ID: 22381897
[TBL] [Abstract][Full Text] [Related]
6. Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo.
Zopf S; Neureiter D; Bouralexis S; Abt T; Glaser KB; Okamoto K; Ganslmayer M; Hahn EG; Herold C; Ocker M
Int J Oncol; 2007 Dec; 31(6):1391-402. PubMed ID: 17982666
[TBL] [Abstract][Full Text] [Related]
7. AR-42 induces apoptosis in human hepatocellular carcinoma cells via HDAC5 inhibition.
Zhang M; Pan Y; Dorfman RG; Chen Z; Liu F; Zhou Q; Huang S; Zhang J; Yang D; Liu J
Oncotarget; 2016 Apr; 7(16):22285-94. PubMed ID: 26993777
[TBL] [Abstract][Full Text] [Related]
8. The Effect of a Histone Deacetylase Inhibitor (AR-42) on Canine Prostate Cancer Growth and Metastasis.
Elshafae SM; Kohart NA; Altstadt LA; Dirksen WP; Rosol TJ
Prostate; 2017 May; 77(7):776-793. PubMed ID: 28181686
[TBL] [Abstract][Full Text] [Related]
9. Increasing ceramides sensitizes genistein-induced melanoma cell apoptosis and growth inhibition.
Ji C; Yang YL; He L; Gu B; Xia JP; Sun WL; Su ZL; Chen B; Bi ZG
Biochem Biophys Res Commun; 2012 May; 421(3):462-7. PubMed ID: 22507982
[TBL] [Abstract][Full Text] [Related]
10. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
[TBL] [Abstract][Full Text] [Related]
12. Synergy of Histone-Deacetylase Inhibitor AR-42 with Cisplatin in Bladder Cancer.
Li DR; Zhang H; Peek E; Wang S; Du L; Li G; Chin AI
J Urol; 2015 Aug; 194(2):547-55. PubMed ID: 25748177
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical assessment of A-674563 as an anti-melanoma agent.
Zou Y; Fan G; Wang X
Biochem Biophys Res Commun; 2016 Aug; 477(1):1-8. PubMed ID: 26970307
[TBL] [Abstract][Full Text] [Related]
14. A novel delta-lactam-based histone deacetylase inhibitor, KBH-A42, induces cell cycle arrest and apoptosis in colon cancer cells.
Kang MR; Kang JS; Han SB; Kim JH; Kim DM; Lee K; Lee CW; Lee KH; Lee CH; Han G; Kang JS; Kim HM; Park SK
Biochem Pharmacol; 2009 Sep; 78(5):486-94. PubMed ID: 19445901
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth.
Burns SS; Akhmametyeva EM; Oblinger JL; Bush ML; Huang J; Senner V; Chen CS; Jacob A; Welling DB; Chang LS
Cancer Res; 2013 Jan; 73(2):792-803. PubMed ID: 23151902
[TBL] [Abstract][Full Text] [Related]
16. Discovery of PAT-1102, a novel, potent and orally active histone deacetylase inhibitor with antitumor activity in cancer mouse models.
Hiriyan J; Shivarudraiah P; Gavara G; Annamalai P; Natesan S; Sambasivam G; Sukumaran SK
Anticancer Res; 2015 Jan; 35(1):229-37. PubMed ID: 25550555
[TBL] [Abstract][Full Text] [Related]
17. Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth.
Hartmann D; Lucks J; Fuchs S; Schiffmann S; Schreiber Y; Ferreirós N; Merkens J; Marschalek R; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2012 Apr; 44(4):620-8. PubMed ID: 22230369
[TBL] [Abstract][Full Text] [Related]
18. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS
BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585
[TBL] [Abstract][Full Text] [Related]
19. The glucosylceramide synthase inhibitor PDMP sensitizes pancreatic cancer cells to MEK/ERK inhibitor AZD-6244.
Wang T; Wei J; Wang N; Ma JL; Hui PP
Biochem Biophys Res Commun; 2015 Jan; 456(3):821-6. PubMed ID: 25498501
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide.
Ahn EH; Schroeder JJ
Anticancer Res; 2010 Jul; 30(7):2881-4. PubMed ID: 20683027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
